Wedica (Trelagliptin) 100 MG


Wedica indicated for type 2 diabetes mellitus. When the first line treatment of metformin is not achieving the expected glycemic goals. Trelagliptin launched in Japan and manufactured in Bangladesh. which is expected to be initially used for switchover from a daily DPP-4 inhibitor in the clinical setting.

Whatsapp +8801922101029